No Data
No Data
Morgan Stanley Maintains Zoetis(ZTS.US) With Buy Rating, Maintains Target Price $248
Morgan Stanley analyst Erin Wright maintains $Zoetis(ZTS.US)$ with a buy rating, and maintains the target price at $248.According to TipRanks data, the analyst has a success rate of 65.4% and a total
Express News | Lifecome Biochemistry: signed a supply agreement with Solvay Belgium.
10 Health Care Stocks Whale Activity In Today's Session
Global Veterinary Pain Management Market Report 2024-2032, Featuring Assisi Animal Health, Bayer, Chanelle Pharma, Dechra Pharmaceuticals, Eli Lilly, Idexx Laboratories, Norbrook, Vetoquinol & Zoetis
Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly
Is Zoetis Stock Underperforming the Nasdaq?